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Appropriate empiric antimicrobial selection is crucial to the survival of septic shock 
patients.  It is suspected that the use of inadequate empiric therapy occurs commonly in 
practice.  The primary objective of this study was to determine if there is a difference in 
intensive care unit (ICU) length of stay (LOS) among septic shock patients with 
pneumonia who received adequate versus inadequate empiric antimicrobials.  Adequate 
was defined as a lack of exposure to the same antimicrobial class and absence of previous 
cultures reporting resistance to the antimicrobial in the last 90 days.  This was a 
retrospective cohort study of adult patients who were diagnosed with septic shock and 
pneumonia, received IV antimicrobials, and admitted to an ICU at St. Francis 
Indianapolis between March 1, 2011 and September 30, 2015.  Forty-four patients were 
identified to be included in the study after screening.  Of these patients, 13 patients 
(29.5%) received adequate therapy and 31 patients (70.5%) received inadequate therapy.  
ICU LOS was found to have a median of 8.5 days (IQR=7) in adequate group and 7 days 
(IQR=10) in the inadequate group (p=0.776).  This study showed that inadequate 
antimicrobial therapy occurred commonly in this patient sample.  A larger sample size is 
needed to determine the true consequences of inadequate antimicrobial therapy in the 
septic shock patient population.  Enhancements in real time electronic alerts within the 
electronic medical record may be a method that can be utilized to ensure appropriate 





Sepsis and septic shock are conditions that consume considerable health-care 
resources.  Despite advancements in medicine and resources invested in medical care for 
septic shock, the mortality rate remains high and is equivalent to the number of deaths 
from those with acute myocardial infarction annually.1  The appropriate selection and 
quick administration of antimicrobial agents in patients with septic shock is crucial as 
delays have been associated with increased mortality.2  Appropriate selection of 
antimicrobials requires clinicians to perform extensive searches of medical records to 
avoid repeated antimicrobial exposures and avoid antimicrobials that have reported 
resistance in the patient’s medical history in the previous 90 days.3  This is a time 
intensive task that is generally not feasible in the setting of septic shock without posing 
significant risk for delayed therapy initiation. 
Failure to account for previous exposure and previous resistant cultures has led to 
higher rates of inadequate empiric prescribing which has been associated with poor 
outcomes including increased mortality.4-6  Micek and colleagues examined the impact of 
previous and repeated exposure of antimicrobial agents in septic patients with gram 
negative bacteremia and demonstrated an association for greater inappropriate initial 
antimicrobial therapy, increased hospital mortality, increased length of stay and increased 
hospitals costs.7   
At St. Francis Hospital, efforts to ensure appropriate antimicrobial use in septic 
shock patients and in pneumonia patients is primarily facilitated through the use of 
standardized electronic order sets.  However, the current functionality of these order sets 
do not provide prescribers with patient histories of prior antimicrobial exposures nor 
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history of culture data demonstrating resistant organisms to antimicrobials prescribed in a 
real time fashion.  With increasing multidrug resistance and the time sensitive nature of 
antimicrobial administration, it is difficult to definitively ensure empiric therapy is 
adequate in the septic shock patient populations.  The purpose of this study was to 
determine if there is a difference in outcomes of critically ill patients with presumed 
healthcare associated pneumonia (HCAP), ventilator-associated pneumonia (VAP), or 
hospital acquired pneumonia (HAP) with septic shock in patients prescribed adequate vs. 




The primary objective of the study was to determine whether there was a 
difference in ICU length of stay (LOS) among patients with a presumed pneumonia 
infection (including HCAP, VAP or HAP) with the presence of septic shock when treated 
with adequate vs. inadequate empiric antimicrobial therapy.  Secondary objectives 
evaluated for differences in hospital LOS, all-cause hospital mortality, duration of 
mechanical ventilation (MV), need for renal replacement therapy (RRT), safety by 
looking at frequency of Clostridium difficile infections, patient discharge disposition, 
duration of antimicrobial therapy and differences in mortality among patients with culture 
positive vs. culture negative infections. 
Study Design & Definitions 
This study was a retrospective observational cohort study in which patient 
outcomes were compared among two treatment groups identified during the screening 
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process: patients who received adequate and patients who received inadequate empiric 
antimicrobial therapy for their suspected pneumonia.   Adequate antimicrobial therapy 
was defined as a lack of exposure to the antimicrobial or same antimicrobial class 
(penicillin, cephalosporins, carbapenem, other) and lack of previous cultures reporting 
resistance to the antimicrobial therapy in the previous 90 days.3,7 Inadequate therapy was 
defined as re-use of the same antimicrobial or same generation of antimicrobial 
prescribed in the previous 90 days, or if previous cultures from any site in the last 90 days 
reported resistance to the empiric antimicrobial agent prescribed.  
Participants 
Patients 18 years and older with an ICD-9 diagnosis of septic shock (785.52) 
admitted to the intensive care unit at Franciscan St. Francis Health- Indianapolis for a 
minimum of 48 hours between March 1, 2011 and September 30, 2015 and a hospital 
admission within the previous 90 days had their medical records screened retrospectively 
for eligibility for the study.  To be included in the study, patients had to have a 
respiratory culture (sputum, bronchoaveolar (BAL) lavage or mini-BAL) collected within 
24 hours of antimicrobial administration, received IV antimicrobial therapy for a 
suspected HCAP, HAP, or VAP as documented as a primary or secondary ICD-9 code of 
pneumonia (487.0-518.3, 041.89-041.9). Exclusion criteria included patients who resided 
at an outside hospital for greater than 24 hours, received chronic RRT prior to admission, 







Differences in ICU LOS, hospital LOS, and MV duration between adequate and 
inadequate empiric antimicrobials were analyzed using t-tests or non-parametric tests. 
Differences in initiation of MV, initiation of RRT, and incidence of Clostridium difficile 
infections were analyzed using chi-square tests. 
 
RESULTS 
Forty-four patients with septic shock and pneumonia were included in the study.  
As depicted in Table 1, the mean age was 69.5 ± 12 years with 19 males (43.2%) and 25 
females (56.8%).  The average Sequential Organ Failure Assessment (SOFA) score was 
8.0 ± 3.524. Forty-three of the 44 patients had HCAP (97.7%) and 1 patient had HAP 
(2.3%).  The patients were categorized into adequate and inadequate therapy groups, 
which had similar baseline demographics (Table 1).  Most patients received inadequate 
therapy (70.5%) compared to 29.5% of patients receiving adequate therapy.  Of those that 
received inadequate therapy, all of them had reuse of the same antimicrobial class in the 
last 90 days, 4 patients had cultures showing resistance from previous hospital stays 
within the last 90 days (12.9%), and 1 patient had cultures from the current stay that 
showed resistance to empiric therapy (3.2%).  There was not a difference in median ICU 
LOS in the adequate group versus the inadequate group (8.50 days (IQR 3.5-10.5) and 
7.0 days (IQR 3-12), respectively) (p=0.7660). Notably, of the 44 patients captured, 26 
were shown to have positive cultures, with 7 (53.8%) of those in the adequate group and 
19 (61.3%) of those in the inadequate group (p=0.210) (Table 2). Of the patients who had 
positive cultures, there was no significant difference in patients who received adequate 
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and inadequate therapy (p=0.742).  Additionally, no statistically significant differences 
were observed among the secondary objectives of the study (Table 3). 
 
DISCUSSION 
This study demonstrates that inadequate antimicrobial prescribing occurs 
frequently, specifically due to reuse of antimicrobials in the previous 90 days.  Although 
there was no statistical difference found in this study regarding ICU LOS between 
patients receiving adequate and inadequate antimicrobial therapy, previous trials 
evaluating hundreds of patients demonstrated a negative impact on patient care due to 
previous antimicrobial exposure.6-8  Two previous trials that evaluated approximately 
1,500 patients with gram-negative sepsis concluded that previous antimicrobial exposure 
and increased resistance led to increased mortality.6,13 Another study evaluated 
approximately 800 patients with gram-negative sepsis found an increased hospital LOS in 
patients with prior antimicrobial exposure compared to those without prior antimicrobial 
exposure.7 
 Due to the negative outcomes with previous antimicrobial exposure in patients 
with severe infections, attempts should be made to improve prescribing practices.  A 
study was performed using point-of-care decision alerts within the electronic medical 
record when patients had previous exposure to the same antimicrobial class or previous 
positive cultures showing resistance to the antimicrobial in the past 6 months to 
determine its usefulness in preventing inappropriate prescribing.4  The investigators 
found that this type of alert identified more than 40% of patients prescribed inappropriate 
antimicrobial therapy.4 The addition of a real time alert within St. Francis’s electronic 
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medical record could allow for the decrease in frequency of inadequate empiric 
prescribing.  
Studies evaluating adequate empiric antimicrobials in culture negative septic 
shock are limited, despite the high incidence.  In three trials evaluating 3256 septic shock 
patients, only 34.2% of patients were found to have positive blood cultures, with even 
less having positive respiratory cultures.9-11 Antibiotic exposure prior to culture draw, 
sampling errors, presence of slow growing pathogens, or even noninfectious causes for 
their clinical syndrome have been associated with low yield for positive culture 
results.12,13  The lack of research on culture negative septic shock combined with its high 
frequency introduces major barriers for empiric prescribing while maintaining good 
stewardship of broad spectrum antimicrobials.  Consistent with previous studies, this 
study showed a limited positive yield of respiratory cultures in these patients, making it 
difficult to ensure that empiric therapy is adequate to treat the infection.  However, this 
study showed no difference in hospital mortality between patients with positive and 
negative respiratory cultures. 
 This study has several important limitations.  First being the small sample of this 
study, which was included only from ICU patients at St. Francis Hospital; therefore, 
extrapolation to other patient populations may not be accurate.  Additionally, changes in 
antimicrobial stewardship during the study period were not captured, which may have 
affected the prescribing practices within the institution.  Septic shock patients are 
complex and multiple variables can influence their outcomes which could not be 
controlled for within this study.  Lastly, the identification of septic shock patients through 
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billing codes in a retrospective fashion was another limitation in identifying patients who 
met inclusion criteria of this study.    
 
CONCLUSION 
In conclusion, it was observed that a large majority of patients received 
inadequate empiric antimicrobial therapy in patients with septic shock and pneumonia.  
Though the sample size was not large enough to discern any difference in ICU LOS, 
enhancements in real time electronic alerts are warranted to ensure appropriate empiric 
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TABLES & FIGURES 
 
Table 1: Baseline characteristics 




(n=44) p value 
Age – mean ± SD 71 ± 10 66 ± 13 67.9  ±  12 0.402 
Gender (male) – no. (%) 4 (30.8%) 15 (48.4%) 19 (43.2%) 0.282 
SOFA score – mean ± SD 6.62 ± 3.07 8.58 ± 3.59 8.00 ± 3.52 0.092 
Comorbid conditions – no. (%) 
     Heart failure 4 (30.8%) 8 (25.8%) 12 (27.3%) 0.727 
     COPD 9 (69.2%) 23 (74.2%) 32 (72.7%) 0.114 
     Chronic kidney disease 4 (30.8%) 5 (16.1%) 9 (20.5%) 0.414 
     Liver disease 0 (0%) 1 (3.2%) 1 (2.3%) 1.000 
     Diabetes mellitus 7 (53.8%) 13 (41.9%) 20 (45.5%) 0.524 
     Immunosuppression 2 (15.4%) 3 (9.7%) 5 (11.4%) 0.623 
Type of pneumonia – no. (%) 0.512 
     HCAP 13 (100%) 30 (96.8%) 43 (97.7%)  
     HAP 0 (0%) 1 (3.2%) 1 (2.3%)  




























Table 2: Antimicrobial therapy 




(n=44) p value 
Therapy duration – median 
(IQR) 11 (5-14.5) 9 (4-12) 
8 (4.25-
12.75) 0.616 
Prescribing location – no (%) 
     ICU 2 (15.4%) 12 (38.7%) 14 (31.8%)  
     ED 10 (76.9%) 18 (58.1%) 28 (63.6%)  
     Floor 1 (7.7%) 1 (3.2%) 2 (4.6%)  







































Table 3: Outcomes 







Mortality – no. (%) 4 (30.8%) 12 (38.7%) 16 (36.4%) 0.443 
Hospital LOS – median (IQR) 11 (5.5-15) 12 (4-15) 9.5 (5-15) 0.908 
ICU LOS – median (IQR) 8.5 (3.5-10.5) 7 (3-12) 
6.5 (3.25-
15) 0.766 
MV – no. (%) 8 (61.5%) 27 (87.1%) 35 (79.5%) 0.069 
MV duration – median (IQR) 4.5 (2-14.5) 5 (3-10) 5 (3-12) 0.812 
Clostridium difficile – no. (%) 1 (7.7%) 0 (0%) 1 (2.3%) 0.295 












Mortality – no. (%) 11 (42.3%) 5 (27.8%) 16 (36.4%) 0.443 
 
